(Q45358377)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22497450%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Antiviral efficacy of lamivudine versus entecavir in patients with hepatitis B virus-related advanced hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22497450%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22497450%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Kwang-Hyub Han

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22497450%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Sang Hoon Ahn

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22497450%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

6

Chae Yoon Chon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22497450%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

7

Oidov Baatarkhuu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22497450%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Hye Sun Shin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22497450%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Seung Up Kim

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22497450%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Do Young Kim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22497450%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

1 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22497450%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastroenterology and Hepatology

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22497450%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22497450%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22497450%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

1528-1534

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22497450%20AND%20SRC:MED&resulttype=core&format=json

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Hepatocellular carcinoma presenting with bone metastasis: clinical characteristics and prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Chronic hepatitis B and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Efficacy of lamivudine on hepatitis B viral status and liver function in patients with hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Treatment of chronic hepatitis B: Evolution over two decades.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Chronic hepatitis B: update 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Partial virological response to entecavir in treatment-naive patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Hepatitis B: reflections on the current approach to antiviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Antiviral resistance and hepatitis B therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Hepatitis B virus resistance to antiviral drugs: where are we going?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Long-term safety of lamivudine treatment in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Risk of HBV reactivation according to viral status and treatment intensity in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Entecavir is an optional agent to prevent hepatitis B virus (HBV) reactivation: a review of 16 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Hepatitis B virus reactivation after three-dimensional conformal radiotherapy in patients with hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

Clinical and virological responses to clevudine therapy of hepatocelluar carcinoma patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07145.X

10.1111/J.1440-1746.2012.07145.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22497450%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference